Delivery Order SPE2DB20D3101-SPE2DB22FK0T1
- Not listed
- This federal contract award is for the delivery of LUPRON DEPOT 3.75 MG KITS to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which supports the procurement of a comprehensive range of pharmaceutical products and medical supplies for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $75,796.76 firm-fixed-price delivery order is for 4,558,248,353 units of Lupron Depot 11.25 mg 3-month kits, a specialty medication. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award is for the delivery of LUPRON DEPOT 3.75 MG KITS, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $15,113.76 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corporation's Corporate Office division, a major pharmaceutical distributor. The contract has a completion date of September 24, 2024 and was not set aside for any specific business type. Amerisourcebergen holds a larger Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,365.36 firm fixed-price delivery order is for the provision of Lupron Depot 45 mg 6-month medication kits. The contract has an ultimate completion date of June 13, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,184.12 firm fixed-price delivery order is for the supply of Lupron Depot 11.25 mg 3-month kits, a specialty medication used for various medical treatments. The contract has an ultimate completion date of December 10, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award is for the delivery of Lupron Depot 11.25 mg 3-month kits, a specialty pharmaceutical medication, to the Defense Logistics Agency (DLA). The $28,848.40 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This award is part of a $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,547.01 firm-fixed-price delivery order is for the supply of LUPRON DEPOT 3.75 MG KITS, a prescription medication used for the treatment of certain medical conditions. The contract has an ultimate completion date of March 4, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,736.48 firm-fixed-price contract is for the supply of Lupron Depot 3.75 mg kits, a specialty medication. The award has an ultimate completion date of November 22, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, a Delivery Order valued at $12,092.54, is for the supply of Lupron Depot 11.25 mg 3-month kits, a specialty medication. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,237.41, is for the delivery of Lupron Depot 11.25 mg 3-month kits, a specialty medication. This is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB22FK0T1Delivery Order
This federal contract award is for the procurement of Lupron Depot 3.75 mg pharmaceutical kits by the Defense Logistics Agency (DLA) Troop Support Medical. The $13,018.21 firm fixed-price delivery order was issued to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a component of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions globally. The contract does not have a set-aside designation, indicating full and open competition. Amerisourcebergen's parent company is Cencora, Inc., which also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.0k | 6/9/22 |